décembre 14, 2023
Passing a "Canada Pharmacare Act" in 2023 to set up a framework for the drug plan was part of the two-party agreement meant to provide the minority Liberal government parliamentary stability until 2025. While talks remain constructive on following through with the plan, disagreements remain over what exactly the framework should include. A report from the Parliamentary Budget Officer (PBO) found a single-payer system would cost the public sector $11.2 billion more a year starting in 2024-25, before increasing to $13.4 billion a year in 2027-28.
Lire l'article